NEW YORK, Sept. 26 (UPI) -- U.S. investment firm Berkshire Hathaway Monday said it was taking its own medicine with a board-authorized stock repurchase program.
The firm said it had authorization to reduce its cash holdings to $20 billion, but spend no more than that. It would repurchase Class A and Class B shares at no more than a 10 percent premium over the the current book value of the shares.